Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to determine the safety, tolerability, and efficacy of three doses of lecozotan SR 2, 5, 10 mg in combination with a cholinesterase inhibitor in patients with mild to moderate Alzheimer s Disease over 24 weeks.
Critère d'inclusion
- Alzheimer s Desease